instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'FLECAINIDE'? | Vernakalant for Rapid Cardioversion of Recent-Onset Atrial Fibrillation: Results from the SPECTRUM Study.
Rapid restoration of sinus rhythm using pharmacological cardioversion is commonly indicated in patients with symptomatic recent-onset atrial fibrillation (AF). The objectives of this large, international, multicent... | Oral | DrugAdministrationRoute | CC BY | 33206300 | 19,695,564 | 2021-04 |
What was the outcome of reaction 'Dizziness'? | Vernakalant for Rapid Cardioversion of Recent-Onset Atrial Fibrillation: Results from the SPECTRUM Study.
Rapid restoration of sinus rhythm using pharmacological cardioversion is commonly indicated in patients with symptomatic recent-onset atrial fibrillation (AF). The objectives of this large, international, multicent... | Recovered | ReactionOutcome | CC BY | 33206300 | 19,673,350 | 2021-04 |
What was the outcome of reaction 'Sinus arrest'? | Vernakalant for Rapid Cardioversion of Recent-Onset Atrial Fibrillation: Results from the SPECTRUM Study.
Rapid restoration of sinus rhythm using pharmacological cardioversion is commonly indicated in patients with symptomatic recent-onset atrial fibrillation (AF). The objectives of this large, international, multicent... | Recovered | ReactionOutcome | CC BY | 33206300 | 19,695,564 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Combination Therapy Using Prothrombin Complex Concentrate and Vitamin K in Anticoagulated Patients with Traumatic Intracranial Hemorrhage Prevents Progressive Hemorrhagic Injury: A Historically Controlled Study.
Warfarin remains crucially involved in the treatment of patients at thrombotic or thromboembolic risk. Howev... | ASPIRIN, COAGULATION FACTOR IX HUMAN\COAGULATION FACTOR VII HUMAN\COAGULATION FACTOR X HUMAN\PROTEIN C\PROTEIN S HUMAN\PROTHROMBIN, PHYTONADIONE, WARFARIN POTASSIUM | DrugsGivenReaction | CC BY-NC-ND | 33208582 | 18,674,277 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Combination Therapy Using Prothrombin Complex Concentrate and Vitamin K in Anticoagulated Patients with Traumatic Intracranial Hemorrhage Prevents Progressive Hemorrhagic Injury: A Historically Controlled Study.
Warfarin remains crucially involved in the treatment of patients at thrombotic or thromboembolic risk. Howev... | ASPIRIN, COAGULATION FACTOR IX HUMAN\COAGULATION FACTOR VII HUMAN\COAGULATION FACTOR X HUMAN\PROTEIN C\PROTEIN S HUMAN\PROTHROMBIN, PHYTONADIONE, WARFARIN POTASSIUM | DrugsGivenReaction | CC BY-NC-ND | 33208582 | 18,674,277 | 2021-01-15 |
What is the weight of the patient? | Combination Therapy Using Prothrombin Complex Concentrate and Vitamin K in Anticoagulated Patients with Traumatic Intracranial Hemorrhage Prevents Progressive Hemorrhagic Injury: A Historically Controlled Study.
Warfarin remains crucially involved in the treatment of patients at thrombotic or thromboembolic risk. Howev... | 67 kg. | Weight | CC BY-NC-ND | 33208582 | 18,674,277 | 2021-01-15 |
What was the administration route of drug 'COAGULATION FACTOR IX HUMAN\COAGULATION FACTOR VII HUMAN\COAGULATION FACTOR X HUMAN\PROTEIN C\PROTEIN S HUMAN\PROTHROMBIN'? | Combination Therapy Using Prothrombin Complex Concentrate and Vitamin K in Anticoagulated Patients with Traumatic Intracranial Hemorrhage Prevents Progressive Hemorrhagic Injury: A Historically Controlled Study.
Warfarin remains crucially involved in the treatment of patients at thrombotic or thromboembolic risk. Howev... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33208582 | 18,674,277 | 2021-01-15 |
What was the administration route of drug 'PHYTONADIONE'? | Combination Therapy Using Prothrombin Complex Concentrate and Vitamin K in Anticoagulated Patients with Traumatic Intracranial Hemorrhage Prevents Progressive Hemorrhagic Injury: A Historically Controlled Study.
Warfarin remains crucially involved in the treatment of patients at thrombotic or thromboembolic risk. Howev... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33208582 | 18,674,277 | 2021-01-15 |
What was the administration route of drug 'WARFARIN POTASSIUM'? | Combination Therapy Using Prothrombin Complex Concentrate and Vitamin K in Anticoagulated Patients with Traumatic Intracranial Hemorrhage Prevents Progressive Hemorrhagic Injury: A Historically Controlled Study.
Warfarin remains crucially involved in the treatment of patients at thrombotic or thromboembolic risk. Howev... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33208582 | 18,674,277 | 2021-01-15 |
What was the dosage of drug 'COAGULATION FACTOR IX HUMAN\COAGULATION FACTOR VII HUMAN\COAGULATION FACTOR X HUMAN\PROTEIN C\PROTEIN S HUMAN\PROTHROMBIN'? | Combination Therapy Using Prothrombin Complex Concentrate and Vitamin K in Anticoagulated Patients with Traumatic Intracranial Hemorrhage Prevents Progressive Hemorrhagic Injury: A Historically Controlled Study.
Warfarin remains crucially involved in the treatment of patients at thrombotic or thromboembolic risk. Howev... | 1675 | DrugDosageText | CC BY-NC-ND | 33208582 | 18,674,277 | 2021-01-15 |
What was the dosage of drug 'PHYTONADIONE'? | Combination Therapy Using Prothrombin Complex Concentrate and Vitamin K in Anticoagulated Patients with Traumatic Intracranial Hemorrhage Prevents Progressive Hemorrhagic Injury: A Historically Controlled Study.
Warfarin remains crucially involved in the treatment of patients at thrombotic or thromboembolic risk. Howev... | 10?20 MILLIGRAM | DrugDosageText | CC BY-NC-ND | 33208582 | 18,674,277 | 2021-01-15 |
What was the outcome of reaction 'Pneumonia'? | Combination Therapy Using Prothrombin Complex Concentrate and Vitamin K in Anticoagulated Patients with Traumatic Intracranial Hemorrhage Prevents Progressive Hemorrhagic Injury: A Historically Controlled Study.
Warfarin remains crucially involved in the treatment of patients at thrombotic or thromboembolic risk. Howev... | Fatal | ReactionOutcome | CC BY-NC-ND | 33208582 | 18,674,277 | 2021-01-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | A retrospective review of the real-world experience of the Pegfilgrastim biosimilar (Lapelga®) to the reference biologic (Neulasta®).
BACKGROUND
Cancer patients receiving myelosuppressive chemotherapy are vulnerable to febrile neutropenia (FN) which contributes to poor treatment outcomes. The use of granulocyte colony-... | PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC | 33215563 | 18,558,932 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pain'. | A retrospective review of the real-world experience of the Pegfilgrastim biosimilar (Lapelga®) to the reference biologic (Neulasta®).
BACKGROUND
Cancer patients receiving myelosuppressive chemotherapy are vulnerable to febrile neutropenia (FN) which contributes to poor treatment outcomes. The use of granulocyte colony-... | PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC | 33215563 | 18,558,932 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Standardized Supportive Care Documentation Improves Safety of High-Dose Methotrexate Treatment.
High-dose (HD) methotrexate (MTX) is an essential component of treatment protocols in acute lymphoblastic leukemia, aggressive lymphoma, and osteosarcoma. However, delayed MTX clearance may lead to life-threatening toxicitie... | LEUCOVORIN, METHOTREXATE, PANTOPRAZOLE, SODIUM BICARBONATE | DrugsGivenReaction | CC BY-NC-ND | 33215763 | 19,172,964 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Standardized Supportive Care Documentation Improves Safety of High-Dose Methotrexate Treatment.
High-dose (HD) methotrexate (MTX) is an essential component of treatment protocols in acute lymphoblastic leukemia, aggressive lymphoma, and osteosarcoma. However, delayed MTX clearance may lead to life-threatening toxicitie... | LEUCOVORIN, METHOTREXATE, PANTOPRAZOLE, SODIUM BICARBONATE | DrugsGivenReaction | CC BY-NC-ND | 33215763 | 19,196,320 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Labelled drug-drug interaction medication error'. | Standardized Supportive Care Documentation Improves Safety of High-Dose Methotrexate Treatment.
High-dose (HD) methotrexate (MTX) is an essential component of treatment protocols in acute lymphoblastic leukemia, aggressive lymphoma, and osteosarcoma. However, delayed MTX clearance may lead to life-threatening toxicitie... | LEUCOVORIN, METHOTREXATE, PANTOPRAZOLE, SODIUM BICARBONATE | DrugsGivenReaction | CC BY-NC-ND | 33215763 | 19,172,964 | 2021-02 |
What was the administration route of drug 'METHOTREXATE'? | Standardized Supportive Care Documentation Improves Safety of High-Dose Methotrexate Treatment.
High-dose (HD) methotrexate (MTX) is an essential component of treatment protocols in acute lymphoblastic leukemia, aggressive lymphoma, and osteosarcoma. However, delayed MTX clearance may lead to life-threatening toxicitie... | Other | DrugAdministrationRoute | CC BY-NC-ND | 33215763 | 19,196,320 | 2021-02 |
What was the administration route of drug 'PANTOPRAZOLE'? | Standardized Supportive Care Documentation Improves Safety of High-Dose Methotrexate Treatment.
High-dose (HD) methotrexate (MTX) is an essential component of treatment protocols in acute lymphoblastic leukemia, aggressive lymphoma, and osteosarcoma. However, delayed MTX clearance may lead to life-threatening toxicitie... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33215763 | 19,172,964 | 2021-02 |
What was the administration route of drug 'SODIUM BICARBONATE'? | Standardized Supportive Care Documentation Improves Safety of High-Dose Methotrexate Treatment.
High-dose (HD) methotrexate (MTX) is an essential component of treatment protocols in acute lymphoblastic leukemia, aggressive lymphoma, and osteosarcoma. However, delayed MTX clearance may lead to life-threatening toxicitie... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33215763 | 19,172,964 | 2021-02 |
What was the dosage of drug 'SODIUM BICARBONATE'? | Standardized Supportive Care Documentation Improves Safety of High-Dose Methotrexate Treatment.
High-dose (HD) methotrexate (MTX) is an essential component of treatment protocols in acute lymphoblastic leukemia, aggressive lymphoma, and osteosarcoma. However, delayed MTX clearance may lead to life-threatening toxicitie... | CYCLICAL | DrugDosageText | CC BY-NC-ND | 33215763 | 19,172,964 | 2021-02 |
What was the outcome of reaction 'Acute kidney injury'? | Standardized Supportive Care Documentation Improves Safety of High-Dose Methotrexate Treatment.
High-dose (HD) methotrexate (MTX) is an essential component of treatment protocols in acute lymphoblastic leukemia, aggressive lymphoma, and osteosarcoma. However, delayed MTX clearance may lead to life-threatening toxicitie... | Recovered | ReactionOutcome | CC BY-NC-ND | 33215763 | 19,172,964 | 2021-02 |
What was the outcome of reaction 'Labelled drug-drug interaction medication error'? | Standardized Supportive Care Documentation Improves Safety of High-Dose Methotrexate Treatment.
High-dose (HD) methotrexate (MTX) is an essential component of treatment protocols in acute lymphoblastic leukemia, aggressive lymphoma, and osteosarcoma. However, delayed MTX clearance may lead to life-threatening toxicitie... | Recovered | ReactionOutcome | CC BY-NC-ND | 33215763 | 19,172,964 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | DABRAFENIB MESYLATE, TRAMETINIB DIMETHYL SULFOXIDE | DrugsGivenReaction | CC BY | 33215864 | 18,545,980 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood alkaline phosphatase increased'. | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | DABRAFENIB MESYLATE, TRAMETINIB DIMETHYL SULFOXIDE | DrugsGivenReaction | CC BY | 33215864 | 18,545,980 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | DABRAFENIB, FUROSEMIDE, TRAMETINIB | DrugsGivenReaction | CC BY | 33215864 | 19,564,673 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | DABRAFENIB, FUROSEMIDE, TRAMETINIB | DrugsGivenReaction | CC BY | 33215864 | 19,564,673 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'General physical health deterioration'. | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | DABRAFENIB MESYLATE, TRAMETINIB DIMETHYL SULFOXIDE | DrugsGivenReaction | CC BY | 33215864 | 18,545,980 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic function abnormal'. | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | DABRAFENIB MESYLATE, TRAMETINIB DIMETHYL SULFOXIDE | DrugsGivenReaction | CC BY | 33215864 | 18,545,980 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Interstitial lung disease'. | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | DABRAFENIB MESYLATE, TRAMETINIB DIMETHYL SULFOXIDE | DrugsGivenReaction | CC BY | 33215864 | 18,545,980 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia bacterial'. | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | DABRAFENIB MESYLATE, TRAMETINIB DIMETHYL SULFOXIDE | DrugsGivenReaction | CC BY | 33215864 | 18,545,980 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | DABRAFENIB, FUROSEMIDE, TRAMETINIB | DrugsGivenReaction | CC BY | 33215864 | 19,564,673 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | DABRAFENIB MESYLATE, TRAMETINIB DIMETHYL SULFOXIDE | DrugsGivenReaction | CC BY | 33215864 | 18,545,980 | 2021-01 |
What was the administration route of drug 'DABRAFENIB MESYLATE'? | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | Oral | DrugAdministrationRoute | CC BY | 33215864 | 18,545,980 | 2021-01 |
What was the administration route of drug 'DABRAFENIB'? | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | Oral | DrugAdministrationRoute | CC BY | 33215864 | 19,564,673 | 2021-01 |
What was the administration route of drug 'FUROSEMIDE'? | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | Oral | DrugAdministrationRoute | CC BY | 33215864 | 19,564,673 | 2021-01 |
What was the administration route of drug 'TRAMETINIB DIMETHYL SULFOXIDE'? | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | Oral | DrugAdministrationRoute | CC BY | 33215864 | 18,545,980 | 2021-01 |
What was the administration route of drug 'TRAMETINIB'? | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | Oral | DrugAdministrationRoute | CC BY | 33215864 | 19,564,673 | 2021-01 |
What was the dosage of drug 'DABRAFENIB'? | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | 150 mg (milligrams). | DrugDosage | CC BY | 33215864 | 19,564,673 | 2021-01 |
What was the outcome of reaction 'Condition aggravated'? | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | Recovering | ReactionOutcome | CC BY | 33215864 | 19,564,673 | 2021-01 |
What was the outcome of reaction 'General physical health deterioration'? | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | Recovering | ReactionOutcome | CC BY | 33215864 | 18,545,980 | 2021-01 |
What was the outcome of reaction 'Hypoalbuminaemia'? | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | Recovering | ReactionOutcome | CC BY | 33215864 | 18,545,980 | 2021-01 |
What was the outcome of reaction 'Interstitial lung disease'? | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | Recovering | ReactionOutcome | CC BY | 33215864 | 18,545,980 | 2021-01 |
What was the outcome of reaction 'Pneumonia'? | Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dabrafenib and trametinib therapy for BRAF V600E-mutant non-small cell lung cancer (NSCLC) has demonstrated strong antitumor effects in clinical trials and has been approved for use in clinical pra... | Recovering | ReactionOutcome | CC BY | 33215864 | 19,564,673 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage'. | Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasms.
In patients with BCR-ABL-negative myeloproliferative neoplasms (MPN), arterial or venous thromboembolic events (ATE/VTE) are a major burden. In order to control these complic... | ASPIRIN | DrugsGivenReaction | CC BY | 33216197 | 19,808,389 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Post procedural haemorrhage'. | Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasms.
In patients with BCR-ABL-negative myeloproliferative neoplasms (MPN), arterial or venous thromboembolic events (ATE/VTE) are a major burden. In order to control these complic... | ASPIRIN | DrugsGivenReaction | CC BY | 33216197 | 19,808,389 | 2021-08 |
What was the dosage of drug 'ASPIRIN'? | Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasms.
In patients with BCR-ABL-negative myeloproliferative neoplasms (MPN), arterial or venous thromboembolic events (ATE/VTE) are a major burden. In order to control these complic... | LOW DOSE | DrugDosageText | CC BY | 33216197 | 19,808,389 | 2021-08 |
What was the administration route of drug 'AMIODARONE'? | Recurrent autoimmune myocarditis in a young woman during the coronavirus disease 2019 pandemic.
We report a unique case of a young woman with recurrent immune-mediated (virus-negative) lymphocytic fulminant myocarditis during the coronavirus disease 2019 pandemic. At the first endomyocardial biopsy (EMB)-proven episode... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33225579 | 19,649,870 | 2021-02 |
What was the administration route of drug 'ESMOLOL HYDROCHLORIDE'? | Recurrent autoimmune myocarditis in a young woman during the coronavirus disease 2019 pandemic.
We report a unique case of a young woman with recurrent immune-mediated (virus-negative) lymphocytic fulminant myocarditis during the coronavirus disease 2019 pandemic. At the first endomyocardial biopsy (EMB)-proven episode... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33225579 | 19,625,863 | 2021-02 |
What was the administration route of drug 'LIDOCAINE HYDROCHLORIDE'? | Recurrent autoimmune myocarditis in a young woman during the coronavirus disease 2019 pandemic.
We report a unique case of a young woman with recurrent immune-mediated (virus-negative) lymphocytic fulminant myocarditis during the coronavirus disease 2019 pandemic. At the first endomyocardial biopsy (EMB)-proven episode... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33225579 | 19,649,870 | 2021-02 |
What was the administration route of drug 'LIDOCAINE'? | Recurrent autoimmune myocarditis in a young woman during the coronavirus disease 2019 pandemic.
We report a unique case of a young woman with recurrent immune-mediated (virus-negative) lymphocytic fulminant myocarditis during the coronavirus disease 2019 pandemic. At the first endomyocardial biopsy (EMB)-proven episode... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33225579 | 19,625,863 | 2021-02 |
What was the dosage of drug 'AMIODARONE'? | Recurrent autoimmune myocarditis in a young woman during the coronavirus disease 2019 pandemic.
We report a unique case of a young woman with recurrent immune-mediated (virus-negative) lymphocytic fulminant myocarditis during the coronavirus disease 2019 pandemic. At the first endomyocardial biopsy (EMB)-proven episode... | UNKNOWN | DrugDosageText | CC BY-NC | 33225579 | 19,436,841 | 2021-02 |
What was the outcome of reaction 'Chronic kidney disease'? | Recurrent autoimmune myocarditis in a young woman during the coronavirus disease 2019 pandemic.
We report a unique case of a young woman with recurrent immune-mediated (virus-negative) lymphocytic fulminant myocarditis during the coronavirus disease 2019 pandemic. At the first endomyocardial biopsy (EMB)-proven episode... | Recovered | ReactionOutcome | CC BY-NC | 33225579 | 19,625,863 | 2021-02 |
What was the outcome of reaction 'Hyponatraemia'? | Recurrent autoimmune myocarditis in a young woman during the coronavirus disease 2019 pandemic.
We report a unique case of a young woman with recurrent immune-mediated (virus-negative) lymphocytic fulminant myocarditis during the coronavirus disease 2019 pandemic. At the first endomyocardial biopsy (EMB)-proven episode... | Recovered | ReactionOutcome | CC BY-NC | 33225579 | 19,625,863 | 2021-02 |
What was the outcome of reaction 'Thyroid disorder'? | Recurrent autoimmune myocarditis in a young woman during the coronavirus disease 2019 pandemic.
We report a unique case of a young woman with recurrent immune-mediated (virus-negative) lymphocytic fulminant myocarditis during the coronavirus disease 2019 pandemic. At the first endomyocardial biopsy (EMB)-proven episode... | Recovered | ReactionOutcome | CC BY-NC | 33225579 | 19,625,863 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States.
The US Food and Drug Administration approved a 6-month regimen of pretomanid, bedaquiline, and linezolid for extensively drug-resistant or multidrug-intolerant tuberculosis after a trial in South Africa demonstrated 90% effectiveness 6 months postt... | MOXIFLOXACIN | DrugsGivenReaction | CC BY | 33227229 | 18,924,181 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States.
The US Food and Drug Administration approved a 6-month regimen of pretomanid, bedaquiline, and linezolid for extensively drug-resistant or multidrug-intolerant tuberculosis after a trial in South Africa demonstrated 90% effectiveness 6 months postt... | BEDAQUILINE FUMARATE, ISONIAZID, LINEZOLID, PRETOMANID, RIFAMPIN | DrugsGivenReaction | CC BY | 33227229 | 18,593,672 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States.
The US Food and Drug Administration approved a 6-month regimen of pretomanid, bedaquiline, and linezolid for extensively drug-resistant or multidrug-intolerant tuberculosis after a trial in South Africa demonstrated 90% effectiveness 6 months postt... | MOXIFLOXACIN | DrugsGivenReaction | CC BY | 33227229 | 18,924,181 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States.
The US Food and Drug Administration approved a 6-month regimen of pretomanid, bedaquiline, and linezolid for extensively drug-resistant or multidrug-intolerant tuberculosis after a trial in South Africa demonstrated 90% effectiveness 6 months postt... | MOXIFLOXACIN | DrugsGivenReaction | CC BY | 33227229 | 18,924,181 | 2021-01 |
What was the administration route of drug 'BEDAQUILINE FUMARATE'? | Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States.
The US Food and Drug Administration approved a 6-month regimen of pretomanid, bedaquiline, and linezolid for extensively drug-resistant or multidrug-intolerant tuberculosis after a trial in South Africa demonstrated 90% effectiveness 6 months postt... | Oral | DrugAdministrationRoute | CC BY | 33227229 | 18,593,672 | 2021-01 |
What was the dosage of drug 'ISONIAZID'? | Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States.
The US Food and Drug Administration approved a 6-month regimen of pretomanid, bedaquiline, and linezolid for extensively drug-resistant or multidrug-intolerant tuberculosis after a trial in South Africa demonstrated 90% effectiveness 6 months postt... | 600 mg (milligrams). | DrugDosage | CC BY | 33227229 | 18,593,672 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to bone'. | Enhanced toxicity with CDK 4/6 inhibitors and palliative radiotherapy: Non-consecutive case series and review of the literature.
Current first-line systemic treatment in most patients with metastatic hormone receptor-positive, HER-2 negative breast cancer is an aromatase inhibitor in combination with a cyclin dependant... | CYCLOPHOSPHAMIDE, DOCETAXEL, DOXORUBICIN HYDROCHLORIDE, LETROZOLE, PALBOCICLIB, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY-NC-ND | 33227663 | 18,675,217 | 2021-01 |
What was the outcome of reaction 'Oesophagitis'? | Enhanced toxicity with CDK 4/6 inhibitors and palliative radiotherapy: Non-consecutive case series and review of the literature.
Current first-line systemic treatment in most patients with metastatic hormone receptor-positive, HER-2 negative breast cancer is an aromatase inhibitor in combination with a cyclin dependant... | Recovered | ReactionOutcome | CC BY-NC-ND | 33227663 | 19,614,450 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diabetic ketoacidosis'. | A Remarkable Elevation in the Procalcitonin Levels Due to Diabetic Ketoacidosis in a Hemodialysis Patient.
Procalcitonin (PCT), a marker of the inflammatory response during infections, can be elevated by diabetic ketoacidosis (DKA). A male patient in his 50s with diabetic nephropathy on hemodialysis presented with vomi... | ALFACALCIDOL, AMITRIPTYLINE HYDROCHLORIDE, ATORVASTATIN CALCIUM, BIXALOMER, CALCIUM CARBONATE, INSULIN ASPART, INSULIN GLARGINE, RABEPRAZOLE SODIUM | DrugsGivenReaction | CC BY-NC-ND | 33229806 | 19,958,472 | 2021-04-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product dose omission issue'. | A Remarkable Elevation in the Procalcitonin Levels Due to Diabetic Ketoacidosis in a Hemodialysis Patient.
Procalcitonin (PCT), a marker of the inflammatory response during infections, can be elevated by diabetic ketoacidosis (DKA). A male patient in his 50s with diabetic nephropathy on hemodialysis presented with vomi... | ALFACALCIDOL, AMITRIPTYLINE HYDROCHLORIDE, ATORVASTATIN CALCIUM, BIXALOMER, CALCIUM CARBONATE, INSULIN ASPART, INSULIN GLARGINE, RABEPRAZOLE SODIUM | DrugsGivenReaction | CC BY-NC-ND | 33229806 | 19,958,472 | 2021-04-15 |
What is the weight of the patient? | A Remarkable Elevation in the Procalcitonin Levels Due to Diabetic Ketoacidosis in a Hemodialysis Patient.
Procalcitonin (PCT), a marker of the inflammatory response during infections, can be elevated by diabetic ketoacidosis (DKA). A male patient in his 50s with diabetic nephropathy on hemodialysis presented with vomi... | 57.6 kg. | Weight | CC BY-NC-ND | 33229806 | 19,958,472 | 2021-04-15 |
What was the dosage of drug 'INSULIN ASPART'? | A Remarkable Elevation in the Procalcitonin Levels Due to Diabetic Ketoacidosis in a Hemodialysis Patient.
Procalcitonin (PCT), a marker of the inflammatory response during infections, can be elevated by diabetic ketoacidosis (DKA). A male patient in his 50s with diabetic nephropathy on hemodialysis presented with vomi... | 6 IU, TID (BREAKFAST, LUNCH, DINNER) | DrugDosageText | CC BY-NC-ND | 33229806 | 19,958,472 | 2021-04-15 |
What was the dosage of drug 'INSULIN GLARGINE'? | A Remarkable Elevation in the Procalcitonin Levels Due to Diabetic Ketoacidosis in a Hemodialysis Patient.
Procalcitonin (PCT), a marker of the inflammatory response during infections, can be elevated by diabetic ketoacidosis (DKA). A male patient in his 50s with diabetic nephropathy on hemodialysis presented with vomi... | 10 IU, QD (BEDTIME) | DrugDosageText | CC BY-NC-ND | 33229806 | 19,958,472 | 2021-04-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Real-world bone turnover marker use: impact on treatment decisions and fracture.
The use of bone turnover marker (BTM) testing for patients with osteoporosis in the USA has not been well characterized. This retrospective US-based real-world data study found BTM testing has some association with treatment decision-makin... | DENOSUMAB | DrugsGivenReaction | CC BY-NC | 33236195 | 19,311,011 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Femur fracture'. | Real-world bone turnover marker use: impact on treatment decisions and fracture.
The use of bone turnover marker (BTM) testing for patients with osteoporosis in the USA has not been well characterized. This retrospective US-based real-world data study found BTM testing has some association with treatment decision-makin... | DENOSUMAB | DrugsGivenReaction | CC BY-NC | 33236195 | 19,311,011 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Forearm fracture'. | Real-world bone turnover marker use: impact on treatment decisions and fracture.
The use of bone turnover marker (BTM) testing for patients with osteoporosis in the USA has not been well characterized. This retrospective US-based real-world data study found BTM testing has some association with treatment decision-makin... | DENOSUMAB | DrugsGivenReaction | CC BY-NC | 33236195 | 19,311,011 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hip fracture'. | Real-world bone turnover marker use: impact on treatment decisions and fracture.
The use of bone turnover marker (BTM) testing for patients with osteoporosis in the USA has not been well characterized. This retrospective US-based real-world data study found BTM testing has some association with treatment decision-makin... | DENOSUMAB | DrugsGivenReaction | CC BY-NC | 33236195 | 19,311,011 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Spinal fracture'. | Real-world bone turnover marker use: impact on treatment decisions and fracture.
The use of bone turnover marker (BTM) testing for patients with osteoporosis in the USA has not been well characterized. This retrospective US-based real-world data study found BTM testing has some association with treatment decision-makin... | DENOSUMAB | DrugsGivenReaction | CC BY-NC | 33236195 | 19,311,011 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Wrist fracture'. | Real-world bone turnover marker use: impact on treatment decisions and fracture.
The use of bone turnover marker (BTM) testing for patients with osteoporosis in the USA has not been well characterized. This retrospective US-based real-world data study found BTM testing has some association with treatment decision-makin... | DENOSUMAB | DrugsGivenReaction | CC BY-NC | 33236195 | 19,311,011 | 2021-05 |
What was the outcome of reaction 'Death'? | Real-world bone turnover marker use: impact on treatment decisions and fracture.
The use of bone turnover marker (BTM) testing for patients with osteoporosis in the USA has not been well characterized. This retrospective US-based real-world data study found BTM testing has some association with treatment decision-makin... | Fatal | ReactionOutcome | CC BY-NC | 33236195 | 19,311,011 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience
Gemcitabine, dexamethasone and cisplatin (GDP) is a well-established salvage regimen for relapsed and refractory lymphomas. In this study, we aimed to s... | CISPLATIN, DEXAMETHASONE, GEMCITABINE, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, RITUXIMAB | DrugsGivenReaction | CC BY | 33237657 | 18,592,629 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience
Gemcitabine, dexamethasone and cisplatin (GDP) is a well-established salvage regimen for relapsed and refractory lymphomas. In this study, we aimed to s... | CISPLATIN, DEXAMETHASONE, GEMCITABINE, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, RITUXIMAB | DrugsGivenReaction | CC BY | 33237657 | 18,592,629 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience
Gemcitabine, dexamethasone and cisplatin (GDP) is a well-established salvage regimen for relapsed and refractory lymphomas. In this study, we aimed to s... | CISPLATIN, DEXAMETHASONE, GEMCITABINE, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, RITUXIMAB | DrugsGivenReaction | CC BY | 33237657 | 18,592,629 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mucosal inflammation'. | Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience
Gemcitabine, dexamethasone and cisplatin (GDP) is a well-established salvage regimen for relapsed and refractory lymphomas. In this study, we aimed to s... | CISPLATIN, DEXAMETHASONE, GEMCITABINE, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, RITUXIMAB | DrugsGivenReaction | CC BY | 33237657 | 18,592,629 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephropathy toxic'. | Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience
Gemcitabine, dexamethasone and cisplatin (GDP) is a well-established salvage regimen for relapsed and refractory lymphomas. In this study, we aimed to s... | CISPLATIN, DEXAMETHASONE, GEMCITABINE, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, RITUXIMAB | DrugsGivenReaction | CC BY | 33237657 | 18,592,629 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience
Gemcitabine, dexamethasone and cisplatin (GDP) is a well-established salvage regimen for relapsed and refractory lymphomas. In this study, we aimed to s... | CISPLATIN, DEXAMETHASONE, GEMCITABINE, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, RITUXIMAB | DrugsGivenReaction | CC BY | 33237657 | 18,592,629 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience
Gemcitabine, dexamethasone and cisplatin (GDP) is a well-established salvage regimen for relapsed and refractory lymphomas. In this study, we aimed to s... | CISPLATIN, DEXAMETHASONE, GEMCITABINE, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, RITUXIMAB | DrugsGivenReaction | CC BY | 33237657 | 18,592,629 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ototoxicity'. | Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience
Gemcitabine, dexamethasone and cisplatin (GDP) is a well-established salvage regimen for relapsed and refractory lymphomas. In this study, we aimed to s... | CISPLATIN, DEXAMETHASONE, GEMCITABINE, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, RITUXIMAB | DrugsGivenReaction | CC BY | 33237657 | 18,592,629 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Platelet count decreased'. | Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience
Gemcitabine, dexamethasone and cisplatin (GDP) is a well-established salvage regimen for relapsed and refractory lymphomas. In this study, we aimed to s... | CISPLATIN, DEXAMETHASONE, GEMCITABINE, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, RITUXIMAB | DrugsGivenReaction | CC BY | 33237657 | 18,592,629 | 2021-04-30 |
What was the dosage of drug 'CISPLATIN'? | Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience
Gemcitabine, dexamethasone and cisplatin (GDP) is a well-established salvage regimen for relapsed and refractory lymphomas. In this study, we aimed to s... | 75 MG/M2 ON DAY 1 | DrugDosageText | CC BY | 33237657 | 18,592,629 | 2021-04-30 |
What was the dosage of drug 'DEXAMETHASONE'? | Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience
Gemcitabine, dexamethasone and cisplatin (GDP) is a well-established salvage regimen for relapsed and refractory lymphomas. In this study, we aimed to s... | 40 MG ON DAY 1, 2, 3, 4 | DrugDosageText | CC BY | 33237657 | 18,592,629 | 2021-04-30 |
What was the dosage of drug 'GEMCITABINE'? | Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience
Gemcitabine, dexamethasone and cisplatin (GDP) is a well-established salvage regimen for relapsed and refractory lymphomas. In this study, we aimed to s... | 1000 MG/M2 ON DAYS 1 AND 8 | DrugDosageText | CC BY | 33237657 | 18,592,629 | 2021-04-30 |
What was the dosage of drug 'GRANULOCYTE COLONY-STIMULATING FACTOR NOS'? | Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience
Gemcitabine, dexamethasone and cisplatin (GDP) is a well-established salvage regimen for relapsed and refractory lymphomas. In this study, we aimed to s... | 2 X 5 UG/KG/DAY | DrugDosageText | CC BY | 33237657 | 18,592,629 | 2021-04-30 |
What was the dosage of drug 'RITUXIMAB'? | Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience
Gemcitabine, dexamethasone and cisplatin (GDP) is a well-established salvage regimen for relapsed and refractory lymphomas. In this study, we aimed to s... | 375 MG/M2, CYCLIC | DrugDosageText | CC BY | 33237657 | 18,592,629 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute graft versus host disease'. | The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation.
Outcomes of allogeneic hematopoietic stem cell transplantation (allo- HSCT) have improved in the recent decade; however, infections and graft-versus-host disease remain two leading complications signifi... | BUSULFAN, FLUDARABINE PHOSPHATE, LEVOFLOXACIN, MEROPENEM | DrugsGivenReaction | CC BY-NC | 33241674 | 19,317,760 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Clostridium difficile infection'. | The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation.
Outcomes of allogeneic hematopoietic stem cell transplantation (allo- HSCT) have improved in the recent decade; however, infections and graft-versus-host disease remain two leading complications signifi... | BUSULFAN, FLUDARABINE PHOSPHATE, LEVOFLOXACIN, MEROPENEM | DrugsGivenReaction | CC BY-NC | 33241674 | 19,317,760 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation.
Outcomes of allogeneic hematopoietic stem cell transplantation (allo- HSCT) have improved in the recent decade; however, infections and graft-versus-host disease remain two leading complications signifi... | BUSULFAN, FLUDARABINE PHOSPHATE, LEVOFLOXACIN, MEROPENEM | DrugsGivenReaction | CC BY-NC | 33241674 | 19,317,760 | 2021-04-01 |
What was the administration route of drug 'VANCOMYCIN'? | The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation.
Outcomes of allogeneic hematopoietic stem cell transplantation (allo- HSCT) have improved in the recent decade; however, infections and graft-versus-host disease remain two leading complications signifi... | Oral | DrugAdministrationRoute | CC BY-NC | 33241674 | 19,323,303 | 2021-04-01 |
What was the dosage of drug 'BUSULFAN'? | The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation.
Outcomes of allogeneic hematopoietic stem cell transplantation (allo- HSCT) have improved in the recent decade; however, infections and graft-versus-host disease remain two leading complications signifi... | MYELOABLATIVE CONDITIONING | DrugDosageText | CC BY-NC | 33241674 | 19,317,760 | 2021-04-01 |
What was the dosage of drug 'FLUDARABINE PHOSPHATE'? | The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation.
Outcomes of allogeneic hematopoietic stem cell transplantation (allo- HSCT) have improved in the recent decade; however, infections and graft-versus-host disease remain two leading complications signifi... | MYELOABLATIVE CONDITIONING | DrugDosageText | CC BY-NC | 33241674 | 19,317,760 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple-drug resistance'. | Triacetyluridine treats epileptic encephalopathy from CAD mutations: a case report and review.
Refractory epilepsy and encephalopathy are frequently encountered in patients with inborn errors of metabolism. We report a case of an 8-year-old girl with history of developmental delay, autism and intractable epilepsy that ... | CANNABIDIOL, CARBAMAZEPINE, CLOBAZAM, LEVETIRACETAM, PHENYTOIN | DrugsGivenReaction | CC BY | 33249780 | 18,954,694 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Parainfluenzae virus infection'. | Triacetyluridine treats epileptic encephalopathy from CAD mutations: a case report and review.
Refractory epilepsy and encephalopathy are frequently encountered in patients with inborn errors of metabolism. We report a case of an 8-year-old girl with history of developmental delay, autism and intractable epilepsy that ... | CANNABIDIOL, CARBAMAZEPINE, CLOBAZAM, LEVETIRACETAM, PHENYTOIN | DrugsGivenReaction | CC BY | 33249780 | 18,954,694 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Triacetyluridine treats epileptic encephalopathy from CAD mutations: a case report and review.
Refractory epilepsy and encephalopathy are frequently encountered in patients with inborn errors of metabolism. We report a case of an 8-year-old girl with history of developmental delay, autism and intractable epilepsy that ... | CANNABIDIOL, CARBAMAZEPINE, CLOBAZAM, LEVETIRACETAM, PHENYTOIN | DrugsGivenReaction | CC BY | 33249780 | 18,954,694 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Transaminases increased'. | Triacetyluridine treats epileptic encephalopathy from CAD mutations: a case report and review.
Refractory epilepsy and encephalopathy are frequently encountered in patients with inborn errors of metabolism. We report a case of an 8-year-old girl with history of developmental delay, autism and intractable epilepsy that ... | CANNABIDIOL, CARBAMAZEPINE, CLOBAZAM, LEVETIRACETAM, PHENYTOIN | DrugsGivenReaction | CC BY | 33249780 | 18,954,694 | 2021-01 |
What was the dosage of drug 'PHENYTOIN'? | Triacetyluridine treats epileptic encephalopathy from CAD mutations: a case report and review.
Refractory epilepsy and encephalopathy are frequently encountered in patients with inborn errors of metabolism. We report a case of an 8-year-old girl with history of developmental delay, autism and intractable epilepsy that ... | 5 MILLIGRAMS PER KILOGRAMS PER DAY | DrugDosageText | CC BY | 33249780 | 18,954,694 | 2021-01 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.